Remimazolam vs Propofol as an Induction Agent for Morbid Obesity Patients
Clinical trial NCT05856617 · UNKNOWN
Trial details
- NCT number
- NCT05856617
- Sponsor
- Seoul National University Bundang Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-25
- Primary completion
- 2023-08-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.